This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GBNH Greenbrook TMS (GBNH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Greenbrook TMS Stock (NASDAQ:GBNH) 30 days 90 days 365 days Advanced Chart Get Greenbrook TMS alerts:Sign Up Key Stats Today's Range$0.04▼$0.1050-Day Range$0.05▼$0.3852-Week Range$0.10▼$1.82Volume787,000 shsAverage Volume3.60 million shsMarket Capitalization$1.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada. Read More Receive GBNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GBNH Stock News HeadlinesNeuronetics reports preliminary Q4 revenue $22.1M, consensus $18.98MJanuary 13, 2025 | markets.businessinsider.comNeuronetics Provides Business Update and Issues 2025 GuidanceJanuary 13, 2025 | markets.businessinsider.comBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.August 30 at 2:00 AM | Banyan Hill Publishing (Ad)Greenbrook TMS Inc (GBNHF)November 24, 2024 | investing.comGreenbrook TMS Strategic Acquisition and Restructuring by NeuroneticsNovember 22, 2024 | markets.businessinsider.comNeuronetics Sees Q3 Revenue Rise Amid Strategic AcquisitionNovember 13, 2024 | markets.businessinsider.comNeuronetics stockholders approve acquisition of Greenbrook TMSNovember 12, 2024 | markets.businessinsider.comGreenbrook TMS Shareholders Approve Neuronetics AcquisitionNovember 12, 2024 | markets.businessinsider.comSee More Headlines GBNH Stock Analysis - Frequently Asked Questions How were Greenbrook TMS's earnings last quarter? Greenbrook TMS Inc. (NASDAQ:GBNH) posted its quarterly earnings data on Monday, August, 14th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.29) by $0.01. The firm had revenue of $18.35 million for the quarter, compared to the consensus estimate of $19.15 million. What other stocks do shareholders of Greenbrook TMS own? Based on aggregate information from My MarketBeat watchlists, some other companies that Greenbrook TMS investors own include RENN Fund (RCG), Aceragen (ACGN), Alimera Sciences (ALIM), Alpine Summit Energy Partners (ALPS), Angion Biomedica (ANGN), AirMedia Group (ANTE) and Aptorum Group (APM). Company Calendar Last Earnings8/14/2023Today8/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:GBNH CIK1735948 Webwww.greenbrooktms.com Phone(416) 928-6076FaxN/AEmployees492Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$61.73 million Net Margins-83.19% Pretax Margin-83.55% Return on EquityN/A Return on Assets-66.59% Debt Debt-to-Equity RatioN/A Current Ratio0.47 Quick Ratio0.47 Sales & Book Value Annual Sales$69.10 million Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value($1.72) per share Price / Book-0.03Miscellaneous Outstanding Shares40,800,000Free Float31,959,000Market Cap$1.96 million OptionableNot Optionable Beta2.19 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:GBNH) was last updated on 8/30/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenbrook TMS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenbrook TMS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.